1. Home
  2. AVDL vs DGII Comparison

AVDL vs DGII Comparison

Compare AVDL & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.69

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$44.16

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
DGII
Founded
2015
1985
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AVDL
DGII
Price
$21.69
$44.16
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$19.14
$48.80
AVG Volume (30 Days)
1.6M
314.2K
Earning Date
03-02-2026
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.55
EPS
N/A
1.12
Revenue
$248,517,000.00
$448,817,000.00
Revenue This Year
$65.47
$12.80
Revenue Next Year
$30.88
$5.47
P/E Ratio
N/A
$39.92
Revenue Growth
79.88
6.40
52 Week Low
$6.38
$22.39
52 Week High
$23.57
$48.00

Technical Indicators

Market Signals
Indicator
AVDL
DGII
Relative Strength Index (RSI) 63.88 54.89
Support Level $21.52 $38.90
Resistance Level $21.69 $47.73
Average True Range (ATR) 0.06 2.24
MACD -0.01 0.17
Stochastic Oscillator 66.67 70.78

Price Performance

Historical Comparison
AVDL
DGII

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

Share on Social Networks: